• WuXi AppTec Completes OXGENE Acquisition contractpharma
    March 03, 2021
    ​WuXi AppTec has completed the acquisition of OXGENE, a UK-based contract research and development organization that designs and develops scalable gene therapy technologies.
PharmaSources Customer Service